These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15356670

  • 21. A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.
    Grube B, Chong PW, Lau KZ, Orzechowski HD.
    Obesity (Silver Spring); 2013 Jan; 21(1):58-64. PubMed ID: 23505169
    [Abstract] [Full Text] [Related]

  • 22. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J.
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
    Shirai K, Fujita T, Tanaka M, Fujii Y, Shimomasuda M, Sakai S, Samukawa Y.
    Adv Ther; 2019 Jan; 36(1):86-100. PubMed ID: 30535651
    [Abstract] [Full Text] [Related]

  • 24. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
    Chong PW, Beah ZM, Grube B, Riede L.
    Phytother Res; 2014 Oct; 28(10):1520-6. PubMed ID: 24797657
    [Abstract] [Full Text] [Related]

  • 25. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 26. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
    Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C.
    JAMA; 1998 Nov 11; 280(18):1596-600. PubMed ID: 9820262
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of a novel herbal formulation for weight management.
    Stern JS, Peerson J, Mishra AT, Sadasiva Rao MV, Rajeswari KP.
    Obesity (Silver Spring); 2013 May 11; 21(5):921-7. PubMed ID: 23784895
    [Abstract] [Full Text] [Related]

  • 31. Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study.
    Woodgate DE, Conquer JA.
    Curr Ther Res Clin Exp; 2003 Apr 11; 64(4):248-62. PubMed ID: 24944372
    [Abstract] [Full Text] [Related]

  • 32. Twelve weeks CLA supplementation decreases the hip circumference in overweight and obese women. A double-blind, randomized, placebo-controlled trial.
    Mądry E, Chudzicka-Strugała I, Grabańska-Martyńska K, Malikowska K, Grebowiec P, Lisowska A, Bogdański P, Walkowiak J.
    Acta Sci Pol Technol Aliment; 2016 Apr 11; 15(1):107-113. PubMed ID: 28071044
    [Abstract] [Full Text] [Related]

  • 33. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
    Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL.
    Clin Exp Pharmacol Physiol; 2005 Apr 11; 32(1-2):47-53. PubMed ID: 15730434
    [Abstract] [Full Text] [Related]

  • 34. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.
    Anderson JW, Schwartz SM, Hauptman J, Boldrin M, Rossi M, Bansal V, Hale CA.
    Ann Pharmacother; 2006 Oct 11; 40(10):1717-23. PubMed ID: 16940406
    [Abstract] [Full Text] [Related]

  • 35. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May 11; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial.
    Song J, Shin SM, Kim H.
    Medicine (Baltimore); 2019 Nov 11; 98(45):e17922. PubMed ID: 31702673
    [Abstract] [Full Text] [Related]

  • 37. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN, Poppitt SD, McGill AT, Leahy FE, Bennett DA, Lin RB, Ormrod D, Ward L, Strik C, Rodgers A.
    Int J Obes Relat Metab Disord; 2004 Sep 11; 28(9):1149-56. PubMed ID: 15311218
    [Abstract] [Full Text] [Related]

  • 38. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Cho YG, Jung JH, Kang JH, Kwon JS, Yu SP, Baik TG.
    BMC Complement Altern Med; 2017 Jul 28; 17(1):375. PubMed ID: 28754119
    [Abstract] [Full Text] [Related]

  • 39. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E, Kolanowski J, Scheen A, Van Gaal L, ObelHyx Study Group.
    Int J Obes Relat Metab Disord; 2001 Nov 28; 25(11):1713-21. PubMed ID: 11753595
    [Abstract] [Full Text] [Related]

  • 40. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM, Franciscy DM, Wagner HR, Krishnan KR.
    JAMA; 2003 Apr 09; 289(14):1820-5. PubMed ID: 12684361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.